Eden Research (EDEN)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

8.63p
   
  • Change Today:
      0.13p
  • 52 Week High: 11.50
  • 52 Week Low: 7.13
  • Currency: UK Pounds
  • Shares Issued: 207.19m
  • Volume: 61,442
  • Market Cap: 17.87m

Eden Research Overview

Eden Research is in the pharma and biotech sector and is currently trading at 8.63p per share. In the last year Eden Research's share price has ranged from 7.13p to 11.50p and brokers are currently rating this stock as 'strong buy'.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -18.1% -67.6%
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 6.5 8.9
Pr/Book 2.2  
Latest F'cast
Revenue 47.3% -26.3%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Eden Research Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-14 0.10 (3.00) (2.36)p n/a n/a n/a n/a 0.0%
31-Dec-15 0.88 (1.26) (0.74)p n/a n/a n/a n/a 0.0%
31-Dec-16 0.39 (1.91) (1.03)p n/a n/a n/a n/a 0.0%
31-Dec-17 1.88 (0.76) (0.33)p n/a n/a n/a n/a 0.0%
31-Dec-18 2.77 (0.53) (0.16)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Eden Research Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 2.04 (1.38) (0.53)p n/a n/a n/a n/a 0.0%
31-Dec-20 3.63 (0.93) (0.36)p n/a n/a n/a n/a 0.0%
31-Dec-21 6.63 0.08 0.03p 287.5 n/a n/a n/a 0.0%

Copyright © 2020 FactSet Research Systems Inc. All rights reserved.

Eden Research Company Announcements

Year-end trading update 14-Jan-2020 07:00 RNS
Agreement with Corteva Agriscience 08-Jan-2020 07:00 RNS
Regulatory Approval- Organic Production Regulation 07-Jan-2020 07:00 RNS

Latest Eden Research Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

Eden Research Market Data

Currency UK Pounds
Share Price 8.63p
Change Today 0.13p
% Change 1.47 %
52 Week High 11.50
52 Week Low 7.13
Volume 61,442
Shares Issued 207.19m
Market Cap 17.87m

Eden Research Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
11.66% below the market average11.66% below the market average11.66% below the market average11.66% below the market average11.66% below the market average
36.84% below the sector average36.84% below the sector average36.84% below the sector average36.84% below the sector average36.84% below the sector average
Price Trend
48.21% below the market average48.21% below the market average48.21% below the market average48.21% below the market average48.21% below the market average
22.81% below the sector average22.81% below the sector average22.81% below the sector average22.81% below the sector average22.81% below the sector average
Income Not Available
Growth
62.72% above the market average62.72% above the market average62.72% above the market average62.72% above the market average62.72% above the market average
78.38% above the sector average78.38% above the sector average78.38% above the sector average78.38% above the sector average78.38% above the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Eden Research Dividends

No dividends found

Trades for 21-Feb-2020

Time Volume / Share Price
16:17 35,750 @ 8.60p
15:27 12,053 @ 8.60p
11:00 2,420 @ 8.50p
10:06 11,219 @ 8.94p

Eden Research Key Personnel

CFO Alexander John Abrey
CEO Sean M. Smith

Top of Page